Choroidale Neovaskularisation mit Visusminderung bei Pseudoxanthoma elasticum

Mustafa Cumhur Vardarli; Focke Ziemssen; Karl Rudolf Berret

doi:10.1055/a-1141-3659

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd 2021; 238(06): 727-730
DOI: 10.1055/a-1141-3659

Der interessante Fall

Choroidale Neovaskularisation mit Visusminderung bei Pseudoxanthoma elasticum

Choroidal Neovascularization by Pseudoxanthoma Elasticum with Vision Loss

Mustafa Cumhur Vardarli

¹Augenärzte Bad Friedrichshall MVZ GbR

³Praxis Dr. Rudolf Berret, Heilbronn

,

Focke Ziemssen

²Department für Augenheilkunde, Eberhard-Karls-Universität Tübingen

,

Karl Rudolf Berret

³Praxis Dr. Rudolf Berret, Heilbronn

› Author Affiliations

Abstract

Full Text

References

Literatur
1 Nika M, Besirli CG. Choroidal neovascularization and angioid streaks in pseudoxanthoma elasticum. Int J Ophthalmol 2011; 4: 449-451 doi:10.3980/j.issn.2222-3959.2011.04.25
2 Chen KJ. Angioid streaks and other retinopathy in pseudoxanthoma elasticum. JAMA Ophthalmol 2019; 137: e193129 doi:10.1001/jamaophthalmol.2019.3129
3 Uitto J, Li Q, Jiang Q. Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms. J Invest Dermatol 2010; 130: 661-670 doi:10.1038/jid.2009.411
4 Le Saux O, Urban Z, Tschuch C. et al. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet 2000; 25: 223-227 doi:10.1038/76102
5 Battaglia Parodi M, Iacono P, La Spina C. et al. Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks. Am J Ophthalmol 2014; 157: 374-377.2 doi:10.1016/j.ajo.2013.10.015
6 Finger RP, Charbel Issa P, Ladewig M. et al. Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum. Br J Ophthalmol 2008; 92: 483-487 doi:10.1136/bjo.2007.129916
7 Gliem M, Finger RP, Fimmers R. et al. Treatment of choroidal neovascularization due to angioid streaks: a comprehensive review. Retina 2013; 33: 1300-1314 doi:10.1097/IAE.0b013e3182914d2b
8 Kellner U, Kellner S. [Intravitreal drug application]. Klin Monatsbl Augenheilkd 2011; 228: 1015 1017–1030 doi:10.1055/s-0031-1280221
9 Gliem M, Birtel J, Herrmann P. et al. Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study. Graefes Arch Clin Exp Ophthalmol 2020; 258: 311-318 doi:10.1007/s00417-019-04551-4
10 Hess K, Gliem M, Birtel J. et al. Impaired dark adaptation associated with a diseased Bruch membrane in pseudoxanthoma elasticum. Retina 2019;
11 Birtel J, Lindner M, Mishra DK. et al. Retinal imaging including optical coherence tomography angiography for detecting active choroidal neovascularization in pseudoxanthoma elasticum. Clin Exp Ophthalmol 2019; 47: 240-249 doi:10.1111/ceo.13385
12 Li Q, van de Wetering K, Uitto J. Pseudoxanthoma elasticum as a paradigm of heritable ectopic mineralization disorders: pathomechanisms and treatment development. Am J Pathol 2019; 189: 216-225 doi:10.1016/j.ajpath.2018.09.014
13 Laube S, Moss C. Pseudoxanthoma elasticum. Arch Dis Child 2005; 90: 754-756 doi:10.1136/adc.2004.062075
14 Schievink WI, Michels VV, Piepgras DG. Neurovascular manifestations of heritable connective tissue disorders. A review. Stroke 1994; 25: 889-903 doi:10.1161/01.str.25.4.889
15 Schievink WI, Bjornsson J, Piepgras DG. Coexistence of fibromuscular dysplasia and cystic medial necrosis in a patient with Marfanʼs syndrome and bilateral carotid artery dissections. Stroke 1994; 25: 2492-2496 doi:10.1161/01.str.25.12.2492
16 Roach ES, Islam MP. Pseudoxanthoma elasticum. Handb Clin Neurol 2015; 132: 215-221 doi:10.1016/B978-0-444-62702-5.00015-9